Chelation Therapy

Chelation therapy is the administration of a substance called ethylenediamenetetraacetic acid (EDTA) either orally or intravenously to assist the body to eliminate toxic metals.  Toxic metal overload had been known to impair the body’s ability to control free radical activity and as a result may contribute to a number of chronic or acute medical conditions.

EDTA has been known to bind with heavy metals such as lead or mercury, as well as calcium, and remove them from the body, minimizing the toxic load on the body and assisting to restore it to an optimal level of functioning.

Chelation is primarily used at IMI for the treatment of metal toxicity but may also be recommended for the treatment of atherosclerosis (clogged arteries), heart disease, peripheral vascular disease (claudication), diabetes and many other health problems.

EDTA has been used since the 1950s in the treatment of lead poisoning with dramatic results.  EDTA was also the emergency treatment for people with hypercalcaemia (high blood levels of calcium) which was also noted to cause a marked improvement in the circulatory status of patients who also had atherosclerosis (hardening of the arteries).  Chelation therapy for the treatment of heart disease remains controversial amongst the medical community but reported benefits are found in clinics across the country.

Indications

• Toxic overload: lead or metal toxicity
• Detoxification
• Atherosclerosis (Heart Disease)

Questions?
If you have any questions about Chelation Therapy or would like more information on our programs or services, you can contact IMI at 403.233.0917 or by email at info@i-medi.org.